ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 22 filers reported holding ARMATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $172 | +142.3% | 57,496 | -7.9% | 0.00% | – |
Q2 2023 | $71 | -33.0% | 62,396 | -1.3% | 0.00% | – |
Q1 2023 | $106 | +16.5% | 63,196 | -14.2% | 0.00% | – |
Q4 2022 | $91 | -100.0% | 73,696 | +5.6% | 0.00% | – |
Q3 2022 | $295,000 | -5.1% | 69,796 | -12.8% | 0.00% | – |
Q2 2022 | $311,000 | -22.1% | 79,996 | -2.1% | 0.00% | – |
Q1 2022 | $399,000 | -14.2% | 81,696 | -3.7% | 0.00% | -100.0% |
Q4 2021 | $465,000 | +21.1% | 84,796 | -20.1% | 0.00% | – |
Q3 2021 | $384,000 | -17.1% | 106,092 | -9.1% | 0.00% | -100.0% |
Q2 2021 | $463,000 | -21.8% | 116,696 | -5.8% | 0.00% | 0.0% |
Q1 2021 | $592,000 | +100.7% | 123,816 | +25.1% | 0.00% | – |
Q4 2020 | $295,000 | -1.3% | 98,996 | +5.7% | 0.00% | – |
Q3 2020 | $299,000 | -10.2% | 93,698 | +10.4% | 0.00% | – |
Q2 2020 | $333,000 | +60.9% | 84,877 | +27.2% | 0.00% | – |
Q1 2020 | $207,000 | -14.1% | 66,727 | -10.0% | 0.00% | – |
Q4 2019 | $241,000 | -13.9% | 74,154 | -2.0% | 0.00% | – |
Q3 2019 | $280,000 | -6.7% | 75,654 | +1.1% | 0.00% | – |
Q2 2019 | $300,000 | – | 74,854 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $442,000 | 0.01% |
SeaCrest Wealth Management, LLC | 17,550 | $68,000 | 0.01% |
SYNOVUS FINANCIAL CORP | 47,903 | $187,000 | 0.00% |
Edgewood Management | 100,000 | $389,000 | 0.00% |
ROYAL BANK OF CANADA | 43 | $0 | 0.00% |
VANGUARD GROUP INC | 273,150 | $1,062,000 | 0.00% |
UBS Group AG | 3,131 | $12,000 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $2,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 13,072 | $51,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 634,530 | $2,468,000 | 0.00% |